Control of tuberculosis in Uganda: A tale of two districts

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 3, 1999, Pages 224-230

  Nuwaha, Fred ^a  

^a MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

Author keywords

Compliance; Hospitalisation; Treatment; Tuberculosis; Uganda

Indexed keywords

ISONIAZID; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILD HOSPITALIZATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE; TUBERCULOSIS; UGANDA;

ADOLESCENT; ADULT; DISEASE NOTIFICATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; TUBERCULOSIS; UGANDA;

EID: 0033067202     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Stott H, Patel A, Sutherland I, et al. The risk of tuberculous infection in Uganda, derived from the findings of National tuberculin surveys in 1958 and 1970. Tubercle 1973; 54: 1-24.
2. Migliori G B, Borghesi A, Adriko C, et al. Tuberculosis and HIV infection association in a rural district of Northern Uganda: epidemiological and clinical considerations. Tubercle Lung Dis 1992; 73: 285-290.
3. Eriki P P, Okwera A, Aisu I, Morrisay B A, Ellner J J, Daniel M T. The influence of Human immune deficiency virus infection on tuberculosis in Kampala Uganda. Am Rev Respir Dis 1991; 143: 185-187.
4. Nuwaha F. The integration of tuberculosis control into primary health care in Uganda during this era of the HIV epidemic. J Comprehensive Health 1995; 6: 46-48.
5. Goodgame W R. Acquired immune deficiency syndrome in Uganda: clinical and social features. N Engl J Med 1990; 323: 383-389.
6. Schulzer M, Fitzgerald J M, Enarson D A, Grzybowski S. An estimate of the future size of the tuberculosis problem in Sub-Saharan Africa resulting from HIV infection. Tubercle Lung Dis 1992; 73: 52-589.
7. Okot-Nwang M, Wabwire-Mangen F, Kagezi V B A. Increasing prevalence of tuberculosis among Mulago hospital admissions Kampala, Uganda. Tubercle Lung Dis 1993;73: 52-58.
8. World Health Organisation. Tuberculosis control and research strategies for the 1990s: Memorandum from a WHO meeting. Bull World Health Organ 1992; 70: 17-21.
9. Fox W. Compliance of patients and physicians: a lesson from tuberculosis 2. Br Med J 1983; 287: 101-105.
10. Nuwaha F. High-compliance in an ambulatory tuberculosis treatment programme in a rural community of Uganda. Int J Tuberc Lung Dis 1999; 3: 79-81.
11. Konde-Lule J K, Musagara M, Musgrave S, Focus group interviews about AIDS in Rakai district of Uganda. Soc Sci Med 1993; 37: 679-684.
12. Murray C J L, Styblo K, Rouillon A. Tuberculosis in developing countries: burden intervention and cost. Bull Int Union Tuberc Lung Dis 1990; 65 (1): 1-24.
13. Barnes P F. The influence of Epidemiological factors on drug resistance rates in tuberculosis. Am Rev Respir Dis 1987; 136: 325-328.
14. Sumartojo E. When tuberculosis treatment fails. A social behavioural account of patient adherence. Am Rev Respir Dis 1993; 147: 1311-1320.
15. Nuwaha F. Factors influencing the completion of treatment among tuberculosis patients in Mbarara district, Uganda. East Afr Med J 1997; 74: 690-693.
16. Sbarbaro J A. Compliance inducements and enforcement. Chest 1979; 76 (suppl): 750-756.
17. Tuberculosis Chemotherapy Centre Madras. A comparison of home and hospital treatment in Madras, India. Bull World Health Organ 1959; 20: 5-45.